tiprankstipranks
FluoroPharma Medical Inc (FPMI)
OTHER OTC:FPMI
US Market
Holding FPMI?
Track your performance easily

FluoroPharma Medical (FPMI) Stock Price & Analysis

1 Followers

FPMI Stock Chart & Stats


Financials

Annual

Ownership Overview

0.34%99.66%
Insiders
Mutual Funds
0.34% Other Institutional Investors
99.66% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

FPMI FAQ

What was FluoroPharma Medical Inc’s price range in the past 12 months?
Currently, no data Available
What is FluoroPharma Medical Inc’s market cap?
Currently, no data Available
When is FluoroPharma Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were FluoroPharma Medical Inc’s earnings last quarter?
Currently, no data Available
Is FluoroPharma Medical Inc overvalued?
According to Wall Street analysts FluoroPharma Medical Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does FluoroPharma Medical Inc pay dividends?
    FluoroPharma Medical Inc does not currently pay dividends.
    What is FluoroPharma Medical Inc’s EPS estimate?
    FluoroPharma Medical Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does FluoroPharma Medical Inc have?
    FluoroPharma Medical Inc has 34,262,000 shares outstanding.
      What happened to FluoroPharma Medical Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of FluoroPharma Medical Inc?
      Currently, no hedge funds are holding shares in FPMI
      ---

      FluoroPharma Medical Stock Smart Score

      10
      Unlock Smart Score
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      FluoroPharma Medical Inc

      FluoroPharma Medical, Inc. engages in the research, development, and commercialization molecular imaging pharmaceuticals with initial applications in the area of cardiology. It focuses on the development of breakthrough positron emission tomography imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Brainstorm Cell Therapeutics
      Cyclacel Pharmaceuticals
      Geron
      Plus Therapeutics
      Popular Stocks
      ---
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis